Parliament Workbench
Data: Motions & questions to 19 Nov 2026 · Votes to 12 Nov 2026

Motion For Debate · S6M-17670 · Session 6

Addressing the Inadequate Provision for Neurodevelopmental Conditions

Carried Lodged by Alex Cole-Hamilton LD Lodged 22 May 2025 Debate 28 May 2025

The motion

That the Parliament recognises the scale of the mental health emergency in Scotland; notes with concern the lack of adequate provision for neurodevelopmental conditions, particularly in the context of a sharp rise in demand for neurodiversity assessments and treatment for adults and children following the COVID-19 pandemic; further notes the additional pressure on services caused by the global shortage of attention deficit hyperactivity disorder (ADHD) medication, which has led to the closure of titration clinics in some areas and significantly impacted waiting times and access to care; recognises the profound distress and disruption this causes for individuals and families who are left without timely diagnosis or support; acknowledges the knock-on effects on child and adolescent mental health services (CAMHS), as well as the wider economic consequences of rising levels of economic inactivity linked to unmet mental health needs; notes the pressure that this puts on GPs and primary care; further notes with concern the widespread removal of shared care arrangements where patients who obtained a private diagnosis could receive ongoing care and medication through the Scottish NHS; expresses disappointment at the Scottish Government’s failure to meet its commitment to allocate 10% of NHS spending to mental health and 1% to CAMHS; calls on the Scottish Government to work urgently with NHS boards and local authorities to devise a robust protocol on the use of shared care arrangements to allow for their use where appropriate, and further calls on the Scottish Government to create neurodevelopmental pathways and stepped care models, as recommended by the National Autism Implementation Team and Royal College of Psychiatrists in the 2021 National Clinical ADHD Pathway Feasibility Study.

What MSPs voted on: the motion as amended

The Liberal Democrats’ motion was rewritten by amendments from the SNP (S6M-17670.3) and Labour (S6M-17670.1) before this vote. A vote ‘for’ was a vote for the motion as amended, not as lodged.

That the Parliament recognises the scale
265 words removed by S6M-17670.3of the mental health emergency in Scotland; notes with concern the lack of adequate provision for neurodevelopmental conditions, particularly in the context of a sharp rise in demand for neurodiversity assessments and treatment for adults and children following the COVID-19 pandemic; further notes the additional pressure on services caused by the global shortage of attention deficit hyperactivity disorder (ADHD) medication, which has led to the closure of titration clinics in some areas and significantly impacted waiting times and access to care; recognises the profound distress and disruption this causes for individuals and families who are left without timely diagnosis or support; acknowledges the knock-on effects on child and adolescent mental health services (CAMHS), as well as the wider economic consequences of rising levels of economic inactivity linked to unmet mental health needs; notes the pressure that this puts on GPs and primary care; further notes with concern the widespread removal of shared care arrangements where patients who obtained a private diagnosis could receive ongoing care and medication through the Scottish NHS; expresses disappointment at the Scottish Government’s failure to meet its commitment to allocate 10% of NHS spending to mental health and 1% to CAMHS; calls on the Scottish Government to work urgently with NHS boards and local authorities to devise a robust protocol on the use of shared care arrangements to allow for their use where appropriate, and further calls on the Scottish Government to create neurodevelopmental pathways and stepped care models, as recommended by the National Autism Implementation Team and Royal College of Psychiatrists in the 2021 National Clinical ADHD Pathway Feasibility Study.
S6M-17670.3 SNP and urgency of unmet need in both mental health and neurodevelopmental support, particularly in the context of a sharp rise in demand for neurodiversity assessments and treatment for adults and children following the COVID-19 pandemic; notes the additional pressure on services caused by the global shortage of attention deficit hyperactivity disorder (ADHD) medication, which has led to the closure of titration clinics in some areas and significantly impacted waiting times and access to care; recognises the profound distress and disruption this causes for individuals and families who are left without timely diagnosis or support; acknowledges the knock-on effects on the health service, as well as the wider economic consequences of rising levels of economic inactivity linked to unmet neurodevelopmental and mental health needs; notes with concern the widespread removal of shared care arrangements where patients who obtained a private diagnosis could receive ongoing care and medication through the Scottish NHS; calls on the Scottish Government to work urgently with NHS boards and local authorities on their shared care arrangement protocols, but understands that decisions around the best course of treatment for patients are for individual clinicians; further calls on the Scottish Government to expand and create adult neurodevelopmental pathways and stepped care models, as recommended by the National Autism Implementation Team and Royal College of Psychiatrists in the 2021 National Clinical ADHD Pathway Feasibility Study; notes the four pilots that the Scottish Government funded following these recommendations, the establishment of a neuro-affirming community of practice and ongoing scoping work on demand and capacity for adult neurodevelopmental services, including work with NHS boards and local authorities on local neurodevelopmental data; calls on the Scottish Government to convene a cross-party summit on addressing waits for neurodevelopmental support and mental health capacity to avert a crisis for individuals and families waiting too long; recognises the progress made towards the Scottish Government’s commitment to allocate 10% of NHS spending to mental health and 1% to CAMHS by the end of the current parliamentary session, and thanks the dedicated NHS and wider workforce for its hard work in providing neurodevelopmental and mental health services in this time of increased demand.S6M-17670.1 Labour , and calls on the Scottish Government to publish data on the number of patients with neurodevelopmental conditions who are being removed from CAMHS waiting lists.

Final wording as read into the Official Report at Decision Time. The marked changes are worked out by this site from the amendment texts and match that wording.

Amendments

  1. S6M-17670.3 SNP Maree Todd Agreed vote, 65–49
  2. S6M-17670.2 Conservative Sandesh Gulhane Defeated vote, 49–66
  3. S6M-17670.1 Labour Paul Sweeney Agreed without a vote, per the Official Report

Vote

1 division
  1. 28 May 2025
    Carried
    96 for, 18 against

Amendments

3
  1. No recorded vote
  2. Defeated
    49 for, 66 against
  3. Carried
    65 for, 49 against

Supporters

No MSP has added their name to this motion.

In the Official Report

5 contributions mention S6M-17670
  1. 28 May 2025
    Neurodevelopmental Conditions
    Liam McArthur LD Meeting of the Parliament

    The next item of business is a debate on motion S6M-17670, in the name of Alex Cole-Hamilton, on addressing the inadequate provision for neurodevelopmental conditions. I invite members who wish to participate in the debate to press their r…

  2. 28 May 2025
    Decision Time
    Alison Johnstone Meeting of the Parliament

    The next question is, that amendment S6M-17670.3, in the name of Maree Todd, which seeks to amend motion S6M-17670, in the name of Alex Cole-Hamilton, on addressing the inadequate provision for neurodevelopmental conditions, be agreed to. …

  3. 28 May 2025
    Decision Time
    Alison Johnstone Meeting of the Parliament

    The next question is, that amendment S6M-17670.2, in the name of Sandesh Gulhane, which seeks to amend motion S6M-17670, in the name of Alex Cole-Hamilton, on addressing the inadequate provision for neurodevelopmental conditions, be agreed…

  4. 28 May 2025
    Decision Time
    Alison Johnstone Meeting of the Parliament

    The next question is, that amendment S6M-17670.1, in the name of Paul Sweeney, which seeks to amend motion S6M-17670, in the name of Alex Cole-Hamilton, on addressing the inadequate provision for neurodevelopmental conditions, be agreed to…

  5. 28 May 2025
    Decision Time
    Alison Johnstone Meeting of the Parliament

    The next question is, that motion S6M-17670, in the name of Alex Cole-Hamilton, on addressing the inadequate provision for neurodevelopmental conditions, as amended, be agreed to. Are we agreed? Members: No.